Skip to main content

Table 4 Distribution of treatment modalities and outcome of study participants

From: Clinical profile and outcome of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 infection: a single-center observational study from South India

Parameters

Frequency (n = 78)

Percentage

Respiratory support

 Low-flow nasal oxygen (LFO)

1

1.2

 High-flow nasal cannula (HFNC)

4

5.1

 Non-invasive ventilation (NIV)

4

5.1

 Mechanical ventilation

2

2.5

Treatment

 Fluid bolus

58

74.4

 Steroids

55

70.5

 IVIg

74

94.9

 Aspirin

49

62.8

 Inotropic support

28

35.9

 Renal support

1

1.2

Outcome

 Death

1

1.2

 Hospital stay (mean ± SD days)

4.7 ± 1.8

 ICU stay (mean ± SD days)

2.8 ± 1.5

  1. ICU Intensive care unit